GlassScriptPhysician profile
Athena C Mason
NPI 1437152774
$5,924.73
in general payments reported to CMS, 2019-2025
43 companies · $1,504 in 2025
The $1,504 reported for 2025 was more than what 92% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $336 · 2021: $726 · 2022: $595 · 2023: $1,288 · 2024: $1,224 · 2025: $1,504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,016.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,015.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $661.76 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $607.66 | 2019-2025 | Airsupra, Farxiga |
| Lilly USA, LLC | $573.15 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $553.22 | 2020-2025 | |
| Glaxosmithkline, LLC. | $444.75 | 2019-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $359.89 | 2022-2025 | |
| Abbott Laboratories | $283.13 | 2019-2025 | Freestyle Libre 3 |
| Novo Nordisk INC | $226.49 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $205.09 | 2019-2025 | Otezla, Repatha, Repatha |
| Exact Sciences Corporation | $168.35 | 2023-2025 | Cologuard Collection Kit |
| Eisai INC. | $156.84 | 2020-2025 | |
| Otsuka America Pharmaceutical, INC. | $155.79 | 2022-2024 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $150.83 | 2019-2024 | Jardiance, Ofev |
| Si-Bone, INC. | $145.20 | 2021 | |
| Janssen Pharmaceuticals, INC | $141.53 | 2021-2025 | Spravato, Xarelto |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Athena Mason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.